Predicting response to neoadjuvant chemotherapy in patients with cervical carcinoma: can we do without any longer?
Author:
Publisher
BMJ
Subject
Obstetrics and Gynecology,Oncology
Reference59 articles.
1. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer--Where Does It Stand?
2. Long-Term Follow-up of the First Randomized Trial Using Neoadjuvant Chemotherapy in Stage Ib Squamous Carcinoma of the Cervix: The Final Results
3. Neoadjuvant chemotherapy (NACT) in cervical cancer: Still promising?
4. Concurrent Chemotherapy and Radiation: A Major Advance for Women With Cervical Cancer
5. Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2–IIA2 cervical cancers;La radiologia medica;2020-05-18
2. Explanation for the failure of neoadjuvant chemotherapy to improve outcomes after radiotherapy for locally advanced uterine cervical cancer from the standpoint of the tumor regression rate;Radiation Medicine;2007-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3